Rare Somatic MEN1 Gene Pathogenic Variant in a Patient Affected by Atypical Parathyroid Adenoma.


Journal

International journal of endocrinology
ISSN: 1687-8337
Titre abrégé: Int J Endocrinol
Pays: Egypt
ID NLM: 101516376

Informations de publication

Date de publication:
2020
Historique:
received: 13 11 2019
revised: 14 02 2020
accepted: 06 03 2020
entrez: 16 5 2020
pubmed: 16 5 2020
medline: 16 5 2020
Statut: epublish

Résumé

Atypical parathyroid adenoma is a rare neoplasm, showing atypical histological features intermediate between classic benign adenoma and the rarest parathyroid carcinoma, whose the clinical behaviour and outcome is not yet understood or predictable. Up to date only two cases of atypical adenoma were found associated to a MEN1 syndrome, and only one was proved to carry a pathogenic variant of the MEN1 gene. We report the clinical, histologic, and molecular findings of a 44-year-old woman, presenting with a histologically proved atypical parathyroid adenoma with an apparent aggressive behaviour. CDC73 gene was screened at germline and somatic levels with no results. Whole exome sequencing performed on DNA extracted from blood leukocytes and tumour tissue revealed a somatic MEN1 gene heterozygous variant, c.912+1G > A, of the splicing donor site of exon 6. On immunohistochemistry, downregulation of the menin protein expression in the neoplastic cells was also observed. We report the second case of a rare association of a somatic MEN1 gene mutation in a patient with atypical parathyroid adenoma. We suggest that MEN1 gene could be an underestimate genetic determinant of these rare histological entities, and we highlight the utility of a complete genetic screening protocol, by the use of next-generation sequencing technology in such undetermined clinical cases with no frank clinical presentation.

Identifiants

pubmed: 32411220
doi: 10.1155/2020/2080797
pmc: PMC7201480
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2080797

Informations de copyright

Copyright © 2020 Luigia Cinque et al.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest to disclose.

Références

Endocr Relat Cancer. 2019 Feb 1;26(2):R53-R72
pubmed: 30475215
Acta Oncol. 2017 Jul;56(7):991-1003
pubmed: 28362521
Curr Opin Oncol. 2006 Jan;18(1):16-22
pubmed: 16357559
Hum Mutat. 2008 Jan;29(1):22-32
pubmed: 17879353
Nat Genet. 2002 Dec;32(4):676-80
pubmed: 12434154
QJM. 1996 Sep;89(9):653-69
pubmed: 8917740
J Cancer Res Clin Oncol. 2019 Aug;145(8):1977-1986
pubmed: 31309300
J Bone Miner Res. 2006 Oct;21(10):1666-71
pubmed: 16995822
Oncotarget. 2018 Apr 17;9(29):20721-20733
pubmed: 29755684
Int J Surg. 2016 Jul;31:10-6
pubmed: 27212590
J Med Genet. 2005 Aug;42(8):e51
pubmed: 16061557
Hum Mutat. 2017 Dec;38(12):1621-1648
pubmed: 28881068
Endocr Relat Cancer. 2019 Jul;26(7):R441-R464
pubmed: 31085770
Endocr Connect. 2017 Nov;6(8):886-891
pubmed: 29097378
Ann Surg Oncol. 2016 Sep;23(9):2889-97
pubmed: 27160525
Endocr Relat Cancer. 2007 Jun;14(2):501-12
pubmed: 17639063
Lancet. 2018 Jan 13;391(10116):168-178
pubmed: 28923463
Clin Endocrinol (Oxf). 2016 Feb;84(2):244-249
pubmed: 25557532
N Engl J Med. 2003 Oct 30;349(18):1722-9
pubmed: 14585940
Adv Anat Pathol. 2005 Mar;12(2):53-61
pubmed: 15731573
Cell Oncol (Dordr). 2012 Dec;35(6):411-22
pubmed: 22987117

Auteurs

Luigia Cinque (L)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Flavia Pugliese (F)

Unit of Endocrinology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Celeste Clemente (C)

Unit of Pathology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Stefano Castellana (S)

Bioinformatic Unit, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Maria Pia Leone (MP)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Danilo de Martino (D)

Unit of General Surgery 2nd and Thoracic Surgery, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Teresa Balsamo (T)

Laboratory of Oncology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Claudia Battista (C)

Unit of Endocrinology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Tommaso Biagini (T)

Bioinformatic Unit, Istituto Mendel-CSS, Rome, Italy.

Paolo Graziano (P)

Unit of Pathology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Marco Castori (M)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Alfredo Scillitani (A)

Unit of Endocrinology, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Vito Guarnieri (V)

Division of Medical Genetics, Fondazione IRCCS Casa Sollievo Della Sofferenza, San Giovanni Rotondo (FG), Italy.

Classifications MeSH